Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Jiang

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Cancer Letters|August 22, 2020
Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133]Jiawei Shou, Liangkun You, Junlin Yao, et al.
Medicine|August 5, 2018
The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysisChen Yang, Hui Jiang, Shaozhuo Huang, et al.
Comprehensive Reviews in Food Science and Food Safety|January 2, 2025
Enhancement of soy protein functionality by conjugation or complexation with polysaccharides or polyphenols: A reviewChao Qiu, Yaxu Meng, Zhiheng Zhang, et al.
Cell Research|February 16, 2022
Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cellsYarui Ma, Qing Zhu, Xiaobing Wang, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|December 8, 2024
Transcriptome profiling of triploid Crassostrea gigas gills indicates the host immune mechanism against bacterial infectionXiumei Liu, Weijun Wang, Haitao Zhao, et al.
Ebiomedicine|March 19, 2019
Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2<sup>+</sup>/calcineurin/Erk pathwayZhen Liu, Liming Jiang, Yiran Li, et al.
ACS Applied Materials & Interfaces|June 1, 2014
Enhanced biocompatibility of PLGA nanofibers with gelatin/nano-hydroxyapatite bone biomimetics incorporationDaowei Li, Haizhu Sun, Liming Jiang, et al.
Plos One|December 18, 2024
Differences in emergency hospitalization trauma patients during and after the COVID-19 pandemicHaifeng Chang, Siyuan Li, Xijie Ke, et al.
Anti-Cancer Drugs|May 2, 2026
Temozolomide-based therapy may remodel the tumor microenvironment and enhance immunotherapy sensitivity in advanced leiomyosarcomaHuijing Tan, Zhuo Li, Jianguo Zhou, et al.
Virus Research|April 17, 2018
Comparison analysis of microRNAs in response to dengue virus type 2 infection between the Vero cell-adapted strain and its source, the clinical C6/36 isolated strainJiajia Yang, Yao Lin, Liming Jiang, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Cancer Letters|August 22, 2020
Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133]Jiawei Shou, Liangkun You, Junlin Yao, et al.
Medicine|August 5, 2018
The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysisChen Yang, Hui Jiang, Shaozhuo Huang, et al.
Comprehensive Reviews in Food Science and Food Safety|January 2, 2025
Enhancement of soy protein functionality by conjugation or complexation with polysaccharides or polyphenols: A reviewChao Qiu, Yaxu Meng, Zhiheng Zhang, et al.
Cell Research|February 16, 2022
Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cellsYarui Ma, Qing Zhu, Xiaobing Wang, et al.
Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics|December 8, 2024
Transcriptome profiling of triploid Crassostrea gigas gills indicates the host immune mechanism against bacterial infectionXiumei Liu, Weijun Wang, Haitao Zhao, et al.
Ebiomedicine|March 19, 2019
Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2<sup>+</sup>/calcineurin/Erk pathwayZhen Liu, Liming Jiang, Yiran Li, et al.
ACS Applied Materials & Interfaces|June 1, 2014
Enhanced biocompatibility of PLGA nanofibers with gelatin/nano-hydroxyapatite bone biomimetics incorporationDaowei Li, Haizhu Sun, Liming Jiang, et al.
Plos One|December 18, 2024
Differences in emergency hospitalization trauma patients during and after the COVID-19 pandemicHaifeng Chang, Siyuan Li, Xijie Ke, et al.
Anti-Cancer Drugs|May 2, 2026
Temozolomide-based therapy may remodel the tumor microenvironment and enhance immunotherapy sensitivity in advanced leiomyosarcomaHuijing Tan, Zhuo Li, Jianguo Zhou, et al.
Virus Research|April 17, 2018
Comparison analysis of microRNAs in response to dengue virus type 2 infection between the Vero cell-adapted strain and its source, the clinical C6/36 isolated strainJiajia Yang, Yao Lin, Liming Jiang, et al.
Pageof 15